🇺🇸 FDA
Pipeline program

Buprenorphine/naloxone

NIDA-15629-1

Unknown small_molecule completed

Quick answer

Buprenorphine/naloxone for Hepatitis C is a Unknown program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Hepatitis C
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials